Guobang Pharma Ltd (605507) — Financial Flexibility Index
Guobang Pharma Ltd (605507) has a Financial Flexibility Index of 0.18x as of September 2025. Free cash flow of CN¥421.85 Million (operating CF CN¥311.27 Million minus capex CN¥110.58 Million) represents 0% of total liabilities (CN¥2.30 Billion). Check Guobang Pharma Ltd (605507) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guobang Pharma Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Guobang Pharma Ltd across 9 annual periods. See working capital to net assets of Guobang Pharma Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Guobang Pharma Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for Guobang Pharma Ltd. For the full company profile including market capitalisation, see 605507 market cap overview.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.34x | CN¥836.99 Million | CN¥559.28 Million | CN¥2.43 Billion | ▼ -16.5% |
| 2024 | 0.41x | CN¥1.13 Billion | CN¥706.41 Million | CN¥2.73 Billion | ▼ -4.6% |
| 2023 | 0.43x | CN¥1.27 Billion | CN¥516.76 Million | CN¥2.92 Billion | ▼ -55.1% |
| 2022 | 0.96x | CN¥1.82 Billion | CN¥1.02 Billion | CN¥1.89 Billion | ▲ +313.8% |
| 2021 | 0.23x | CN¥271.86 Million | CN¥-176.18 Million | CN¥1.17 Billion | ▼ -59.6% |
| 2020 | 0.58x | CN¥1.29 Billion | CN¥767.70 Million | CN¥2.23 Billion | ▲ +18.1% |
| 2019 | 0.49x | CN¥1.05 Billion | CN¥440.86 Million | CN¥2.14 Billion | ▲ +22.8% |
| 2018 | 0.40x | CN¥704.93 Million | CN¥541.68 Million | CN¥1.77 Billion | ▲ +127.3% |
| 2017 | 0.17x | CN¥317.51 Million | CN¥148.03 Million | CN¥1.82 Billion | — |